C1-inhibitor (C1-Inh) is an important inhibitor of the inflammatory response and deficiency of this inhibitor, which may be hereditary or acquired, is associated with recurrent episodes of edema. Recently, an autoimmune form of angioedema has been described that is associated with functional deficiency of C1-Inh and an autoantibody that impedes C1-Inh function. In this report we describe the isolation of C1-Inh from the monocytes and plasma of a patient with autoimmune angioedema and demonstrate that the patient's monocytes secrete structurally and functionally normal C1-Inh, but show that this protein circulates in the patient's plasma in an inactive, structurally altered form. Furthermore, using analytic gel electrophoresis techniques it is demonstrated that the patient's autoantibody facilitates cleavage of normal C1-Inh, by its target proteases, to the same species of C1-Inh that is found circulating in the patient's plasma. This autoantibody facilitated cleavage of normal C1-Inh is apparently a consequence of destabilization of protease/inhibitor complexes. These findings contribute to our understanding of protease/C1-Inh interactions and document important observations on pathogenic mechanisms in autoimmune disease.
J Jackson, R B Sim, K Whaley, C Feighery
Title and authors | Publication | Year |
---|---|---|
Acquired Angioedema in Selected Neoplastic Diseases.
Zając M, Bożek A, Kozłowska R, Grzanka A |
2023 | |
The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease
F Defendi, NM Thielens, G Clavarino, JY Cesbron, C Dumestre-Pérard |
Clinical Reviews in Allergy & Immunology | 2019 |
The role of the complement system in hereditary angioedema
D Csuka, N Veszeli, L Varga, Z Prohászka, H Farkas |
Molecular Immunology | 2017 |
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor
H Farkas, L Varga, D Moldovan, K Obtulowicz, T Shirov, T Machnig, H Feuersenger, J Edelman, D Williams-Herman, M Rojavin |
Annals of Allergy, Asthma & Immunology | 2016 |
Manual of Molecular and Clinical Laboratory Immunology
B Detrick, JL Schmitz, RG Hamilton |
2016 | |
Mass spectral analysis of urine proteomic profiles of dairy cows suffering from clinical ketosis
C Xu, S Shu, C Xia, P Wang, Y Sun, C Xu, C Li |
Veterinary Quarterly | 2015 |
ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients
R Engel, I Rensink, D Roem, M Brouwer, A Kalei, D Perry, S Zeerleder, D Wouters, D Hamann |
Journal of Immunological Methods | 2015 |
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
M Cicardi, W Aberer, A Banerji, M Bas, JA Bernstein, K Bork, T Caballero, H Farkas, A Grumach, AP Kaplan, MA Riedl, M Triggiani, A Zanichelli, B Zuraw |
Allergy | 2014 |
Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema
A Williams, R Kaur, C Swift, J Caldwell |
Journal of asthma and allergy | 2014 |
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic
R Castelli, A Zanichelli, M Cugno |
Immunopharmacology and Immunotoxicology | 2013 |
Acquired C1-inhibitor deficiency and lymphoproliferative disorders: A tight relationship
R Castelli, A Zanichelli, M Cicardi, M Cugno |
Critical Reviews in Oncology/Hematology | 2013 |
A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor–associated angioedema
BL Zuraw, JA Bernstein, DM Lang, T Craig, D Dreyfus, F Hsieh, D Khan, J Sheikh, D Weldon, DI Bernstein, J Blessing-Moore, L Cox, RA Nicklas, J Oppenheimer, JM Portnoy, CR Randolph, DE Schuller, SL Spector, SA Tilles, D Wallace |
Journal of Allergy and Clinical Immunology | 2013 |
The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human
I Schepens, F Jaunin, N Begre, U Läderach, K Marcus, T Hashimoto, B Favre, L Borradori |
PloS one | 2010 |
Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation
M Cugno, R Castelli, M Cicardi |
Autoimmunity Reviews | 2008 |
Angioedema
AP Kaplan |
World Allergy Organization Journal | 2008 |
Structure and Function of C1-Inhibitor
IG Wagenaar-Bos, CE Hack |
Immunology and Allergy Clinics of North America | 2006 |
Acquired Deficiency of the Inhibitor of the First Complement Component: Presentation, Diagnosis, Course, and Conventional Management
LC Zingale, R Castelli, A Zanichelli, M Cicardi |
Immunology and Allergy Clinics of North America | 2006 |
Deficiencies of C1 inhibitor
FS Rosen, AE Davis |
Best Practice & Research Clinical Gastroenterology | 2005 |
Angioedema
AP Kaplan, MW Greaves |
Journal of the American Academy of Dermatology | 2005 |
Urticaria and Angioedema
S Baxi, C Dinakar |
Immunology and Allergy Clinics of North America | 2005 |
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
A Agostoni, E Aygorenpursun, K Binkley, A Blanch, K Bork, L Bouillet, C Bucher, A Castaldo, M Cicardi, A DAVISIII |
Journal of Allergy and Clinical Immunology | 2004 |
Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema
IM Ponce, T Caballero, M Reche, AB Piteiro, MC López-Serrano, G Fontán, M López-Trascasa |
Annals of Allergy Asthma & Immunology | 2002 |
Pathways for bradykinin formation and inflammatory disease
AP Kaplan, K Joseph, M Silverberg |
Journal of Allergy and Clinical Immunology | 2002 |
Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2
V Frémeaux-Bacchi, MT Guinnepain, P Cacoub, MA Dragon-Durey, L Mouthon, J Blouin, P Cherin, J Laurent, JC Piette, WH Fridman, L Weiss, MO Kazatchkine |
The American Journal of Medicine | 2002 |
Mechanism of Action of Anti-C1-Inhibitor Autoantibodies: Prevention of the Formation of Stable C1s-C1-inh Complexes
S He, RB Sim, K Whaley, K Austen |
Molecular Medicine | 1998 |
Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes
EM Wallace, SJ Perkins, RB Sim, AC Willis, C Feighery, J Jackson |
Molecular Medicine | 1997 |
Les angio-œdèmes par déficit en C1 inhibiteur
J Laurent, MT Guinnepain |
Revue Française d'Allergologie et d'Immunologie Clinique | 1997 |
A secondary C1s interaction site on C1-inhibitor is essential for formation of a stable enzyme-inhibitor complex
S He, R B Sim, K Whaley |
FEBS Letters | 1997 |
Urticaria, Angioedema, and Autoimmunity
BL Zuraw |
Clinics in Laboratory Medicine | 1997 |
A solid-phase antibody capture assay for the measurement of Cl-inhibitor consumption in vivo
EM Wallace, C Feighery, J Jackson |
Scandinavian Journal of Clinical & Laboratory Investigation | 1996 |
Autoimmune C1 inhibitor deficiency: Report of eight patients
M Cicardi, G Bisiani, M Cugno, P Spath, A Agostoni |
The American Journal of Medicine | 1993 |
Complement in Health and Disease
K Whaley, M Loos, JM Weiler |
1993 | |
The Complement System
A Agostoni, M Cicardi, M Gardinali, L Bergamaschini |
International journal of immunopathology and pharmacology | 1992 |
Acute consumption of C1 inhibitor in a patient with acquired C1-inhibitor deficiency syndrome
BL Zuraw, LC Altman |
Journal of Allergy and Clinical Immunology | 1991 |
Autoimmune Angioedema: a New Role for Autoantibody in Disease Pathogenesis
J Jackson, C Feighery |
Autoimmunity | 1990 |
Antibody molecules: Mediators of disease and diagnostic tools
C Feighery |
Irish Journal of Medical Science | 1989 |
Autoantibodies
MH Lessof, SP Asper |
American Heart Journal | 1960 |